MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • 2018 International Congress

    Accessing Speech and Language Therapy (SLT) in a Multi-Disciplinary Movement Disorders Clinic (MDC)

    J. Martin, A. Chatterjee (Reading, United Kingdom)

    Objective: To enable access to SLT for patients with Parkinson’s (PwP) in the MDC at the Royal Berkshire Hospital (RBH). Background: A successful bid in…
  • 2018 International Congress

    Task effects on lingual kinematics in dysarthric individuals with Parkinson’s disease: Insights from two cases

    M. Wong (Hong Kong, Hong Kong)

    Objective: The present study investigated the effects of different tasks on lingual kinematics in two individuals diagnosed with idiopathic Parkinson’s disease (PD) using the electromagnetic…
  • 2017 International Congress

    Voice Therapy Normalizes Feedforward and Feedback Networks of the Speech Motor System

    S. Narayana, C. Franklin, E. Peterson, D. Robin, P. Fox, L. Ramig (Memphis, TN, USA)

    Objective: The aim of the study was to isolate the specific effects of the training target of The Lee Silverman Voice Therapy (LSVT) in Parkinson’s…
  • 2017 International Congress

    Speech difficulties are linked to striatal dopaminergic deficits and cognitive decline in early de novo patients with Parkinson’s disease

    S. Polychronis, F. Niccolini, G. Pagano, M. Politis (London, United Kingdom)

    Objective: To investigate whether speech difficulties are associated with striatal dopaminergic deficits and whether are linked to progression of symptoms in early de novo patients…
  • 2017 International Congress

    Parkinson’s disease and progressive dysphagia – consider myasthenia gravis

    P. Urban (Hamburg, Germany)

    Objective: We report on three consecutive patients with Parkinson’s disease, in whom myasthenia gravis turned out responsible for progressive dysphagia. Background: Swallowing dysfunction is common…
  • 2017 International Congress

    Characterizing task-based acoustic variations of vowels in Parkinson’s disease: Preliminary data

    C. Kuo (Harrisonburg, VA, USA)

    Objective: This is a pilot study that examines changes in the acoustic characteristics of vowels across speaking tasks for individuals with Parkinson’s disease (PD). The…
  • 2017 International Congress

    Tongue Strength in PSP

    H. Clark, J. Whitwell, J. Ahlskog, K. Josephs (Rochester, MN, USA)

    Objective: To describe anterior and posterior tongue elevation strength in participants with PSP Background: It is widely recognized that the tongue plays a critical role…
  • 2017 International Congress

    Perceptual and acoustical analysis of speech in multiple system atrophy and progressive supranuclear palsy.

    S. Contardi, A. Gessani, F. Cavallieri, C. Budriesi, A. Bernardi, M. Tondelli, E. Menozzi, A. Chiari, P. Nichelli, F. Valzania (Modena, Italy)

    Objective: The aim of this study was to characterize speech impairment in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) with a standardized approach,…
  • 2017 International Congress

    PD Check-In: Supporting people with Parkinson’s Disease in self-managed maintenance of communication following intensive speech treatment

    A. Finnimore, D. Theodoros, A. Rumbach (Brisbane, Australia)

    Objective: To investigate a supported self-management model of care, PD Check-In, for long term maintenance of speech, communication and quality of life in Parkinson’s Disease…
  • 2017 International Congress

    Longitudinal changes in speech and voice functions after subthalamic stimulation in Parkinson’s disease patients

    T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, K. Kawabata, K. Hara, D. Nakatsubo, S. Maesawa, Y. Kajita, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: To elucidate longitudinal changes of speech and voice functions in Parkinson's disease (PD) patients treated with subthalamic nucleus deep brain stimulation (STN-DBS). Background: Previously,…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley